Progranulin (GP88) is an independent prognostic factor for prostate cancer patients
Taubert H, Abdulrahman A, Eckstein M, Jung R, Guzman J, Weigelt K, Serrero G, Yue B, Geppert CI, Stöhr R, Hartmann A, Wullich B, Wach S (2020)
Publication Type: Conference contribution
Publication year: 2020
Journal
Publisher: AMER ASSOC CANCER RESEARCH
City/Town: PHILADELPHIA
Conference Proceedings Title: CANCER RESEARCH
DOI: 10.1158/1538-7445.AM2020-4327
Authors with CRIS profile
Helge Taubert
Professur für Molekulare Urologie
Amer Abdulrahman
Urologische Klinik
Markus Eckstein
Institute of Pathology
Juan Guzman Galvan
Urologische Klinik
Carol-Immanuel Geppert
Institute of Pathology
Robert Stöhr
Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie
Arndt Hartmann
Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie
Bernd Wullich
Lehrstuhl für Urologie
Sven Wach
Medizinische Fakultät
Involved external institutions
United States (USA) (US)How to cite
APA:
Taubert, H., Abdulrahman, A., Eckstein, M., Jung, R., Guzman, J., Weigelt, K.,... Wach, S. (2020). Progranulin (GP88) is an independent prognostic factor for prostate cancer patients. In CANCER RESEARCH. PHILADELPHIA: AMER ASSOC CANCER RESEARCH.
MLA:
Taubert, Helge, et al. "Progranulin (GP88) is an independent prognostic factor for prostate cancer patients." Proceedings of the AACR Annual Meeting PHILADELPHIA: AMER ASSOC CANCER RESEARCH, 2020.
BibTeX: Download